Blood Thinners Reduce Need for Cardiovascular and Respiratory Support in Certain COVID-19 Patients
Giving moderately ill, hospitalized COVID-19 patients a full dose of a blood thinner improved their chances of leaving the...
medicine focused on developing and delivering
therapies that reestablish tissue and organ function
impaired by disease, trauma or congenital abnormalities.
GENE THERAPY
Phase I Clinical Trial Next Step
TRANSPLANTATION
Mimicking Cancer to Avoid Transplant Rejection
Introduction to The McGowan Institute
To provide a national center of expertise in regenerative medicine.
Watch Our Video
Research Spotlight
UPMC-Pitt Researchers Receive Grant to Advance Liver Organoids.
Read more
Featured News
Double Lung Transplant Done Twice
McGowan Institute for Regenerative Medicine affiliated faculty member Pablo Sanchez, MD, PhD, is an Associate Professor of Cardiothoracic Surgery;...
Researchers Develop Coating for Endotracheal Tubes that Releases Antimicrobial Peptides
In a proof-of-concept study, researchers led by McGowan Institute for Regenerative Medicine affiliated faculty member Riccardo Gottardi, PhD, Assistant...
Finding Inspiration to Rebuild Human Heart Muscle
Advances in cardiac tissue engineering offer hope for an array of useful applications, from heart repair to disease modelling....
Video: Hope vs. Hype of Stem Cell Therapy
